Pakistan denies allowing Iranian aircraft to use its airfields amid U.S.-Iran tensions. President Donald Trump…
New option available for Alzheimer’s patients as FDA approves expanded drug use
The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer’s disease, marking a major milestone for patients.
Related Posts
